rs13409

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4BA1

The NM_002701.6(POU5F1):​c.*238C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.434 in 1,151,312 control chromosomes in the GnomAD database, including 110,166 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 14696 hom., cov: 32)
Exomes 𝑓: 0.43 ( 95470 hom. )

Consequence

POU5F1
NM_002701.6 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.82

Publications

24 publications found
Variant links:
Genes affected
POU5F1 (HGNC:9221): (POU class 5 homeobox 1) This gene encodes a transcription factor containing a POU homeodomain that plays a key role in embryonic development and stem cell pluripotency. Aberrant expression of this gene in adult tissues is associated with tumorigenesis. This gene can participate in a translocation with the Ewing's sarcoma gene on chromosome 21, which also leads to tumor formation. Alternative splicing, as well as usage of alternative AUG and non-AUG translation initiation codons, results in multiple isoforms. One of the AUG start codons is polymorphic in human populations. Related pseudogenes have been identified on chromosomes 1, 3, 8, 10, and 12. [provided by RefSeq, Oct 2013]
TCF19 (HGNC:11629): (transcription factor 19) This gene encodes a protein that contains a PHD-type zinc finger domain and likely functions as a transcription factor. The encoded protein plays a role proliferation and apoptosis of pancreatic beta cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.14).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.473 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POU5F1NM_002701.6 linkc.*238C>T 3_prime_UTR_variant Exon 5 of 5 ENST00000259915.13 NP_002692.2 Q01860-1D2IYK3
TCF19NM_007109.3 linkc.*1646G>A downstream_gene_variant ENST00000376257.8 NP_009040.2 Q9Y242A0A1U9X8M7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POU5F1ENST00000259915.13 linkc.*238C>T 3_prime_UTR_variant Exon 5 of 5 1 NM_002701.6 ENSP00000259915.7 Q01860-1
TCF19ENST00000376257.8 linkc.*1646G>A downstream_gene_variant 1 NM_007109.3 ENSP00000365433.3 Q9Y242

Frequencies

GnomAD3 genomes
AF:
0.439
AC:
66531
AN:
151722
Hom.:
14690
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.479
Gnomad AMI
AF:
0.448
Gnomad AMR
AF:
0.453
Gnomad ASJ
AF:
0.393
Gnomad EAS
AF:
0.380
Gnomad SAS
AF:
0.375
Gnomad FIN
AF:
0.361
Gnomad MID
AF:
0.475
Gnomad NFE
AF:
0.434
Gnomad OTH
AF:
0.414
GnomAD4 exome
AF:
0.434
AC:
433392
AN:
999472
Hom.:
95470
Cov.:
13
AF XY:
0.431
AC XY:
213177
AN XY:
494714
show subpopulations
African (AFR)
AF:
0.479
AC:
10601
AN:
22130
American (AMR)
AF:
0.446
AC:
8560
AN:
19208
Ashkenazi Jewish (ASJ)
AF:
0.406
AC:
6877
AN:
16922
East Asian (EAS)
AF:
0.360
AC:
11853
AN:
32922
South Asian (SAS)
AF:
0.384
AC:
21243
AN:
55382
European-Finnish (FIN)
AF:
0.365
AC:
15700
AN:
43060
Middle Eastern (MID)
AF:
0.403
AC:
1212
AN:
3006
European-Non Finnish (NFE)
AF:
0.444
AC:
338738
AN:
763430
Other (OTH)
AF:
0.429
AC:
18608
AN:
43412
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
12121
24241
36362
48482
60603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9714
19428
29142
38856
48570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.438
AC:
66564
AN:
151840
Hom.:
14696
Cov.:
32
AF XY:
0.433
AC XY:
32130
AN XY:
74212
show subpopulations
African (AFR)
AF:
0.479
AC:
19816
AN:
41382
American (AMR)
AF:
0.453
AC:
6906
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.393
AC:
1362
AN:
3468
East Asian (EAS)
AF:
0.381
AC:
1964
AN:
5154
South Asian (SAS)
AF:
0.373
AC:
1796
AN:
4816
European-Finnish (FIN)
AF:
0.361
AC:
3806
AN:
10544
Middle Eastern (MID)
AF:
0.469
AC:
138
AN:
294
European-Non Finnish (NFE)
AF:
0.434
AC:
29499
AN:
67912
Other (OTH)
AF:
0.413
AC:
868
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1902
3804
5706
7608
9510
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
624
1248
1872
2496
3120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.439
Hom.:
31676
Bravo
AF:
0.448
Asia WGS
AF:
0.398
AC:
1381
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.14
CADD
Benign
16
DANN
Benign
0.93
PhyloP100
2.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13409; hg19: chr6-31132140; COSMIC: COSV52563452; COSMIC: COSV52563452; API